[{"Assets_0_Q1_USD":957723000.0,"CommonStockSharesOutstanding_0_Q1_shares":91284000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-112491000.0,"NetIncomeLoss_1_Q1_USD":-102115000.0,"StockholdersEquity_0_Q1_USD":409275000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190429"}]